Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04751448 · ClinicalTrials.gov registry record
COLON-MD: Colon Cancer Longitudinal Study
A clinical trial of Colon Cancer, sponsored by Baylor Research Institute.
- Recruiting
- Registry status
- 11
- Enrollment target
- 1
- Study location
NCT04751448 is a study of Colon Cancer that is actively recruiting participants, run by Baylor Research Institute. The registered enrollment target is 11 participants, below the 4,456-participant average among 97 other Colon Cancer trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04751448, a study of Colon Cancer, is actively recruiting participants, sponsored by Baylor Research Institute.
- RECRUITING
- Registry status
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this proposal is to identify how the composition of the gut microbiome and diet interact to impact chemotherapy-induced diarrhea incidence and severity.
Conditions Studied
Study Locations (1)
Texas
- Baylor Research Institute - Temple
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2026-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04751448
The ClinicalTrials.gov registry entry for NCT04751448 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,456-participant average among 97 other Colon Cancer trials with a reported enrollment target (100% lower). The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colon Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT04751448 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04751448 about?
NCT04751448 is a clinical study titled "COLON-MD: Colon Cancer Longitudinal Study". The goal of this proposal is to identify how the composition of the gut microbiome and diet interact to impact chemotherapy-induced diarrhea incidence and severity.
What is the current status of trial NCT04751448?
This trial is currently recruiting. The enrollment target is 11 participants. The study started on 2021-02-01. Estimated completion is 2026-06-01.
What conditions does trial NCT04751448 study?
This clinical trial studies the following conditions: Colon Cancer.
Who is sponsoring clinical trial NCT04751448?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04751448 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colon Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
RECRUITING
-
A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors
RECRUITING · Phase 1
-
Brodalumab in the Treatment of Immune-Related Adverse Events
RECRUITING · Phase 1
-
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.